Predict your next investment

HEALTHCARE | Drug Development

See what CB Insights has to offer


Acquired | Acquired

About KC Specialty Therapeutics

KC Specialty Therapeutics is focused on the development of Orphan drugs for indications which affect less than 200,000 people per year.

KC Specialty Therapeutics Headquarter Location

2002 W 39th Ave

Kansas City, Kansas, 66103,

United States


Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.